| Literature DB >> 28928129 |
Nurmaa K Dashzeveg1, Rokana Taftaf1, Erika K Ramos1, Luke Torre-Healy2, Anastasia Chumakova2, Daniel J Silver2, Tyler J Alban2, Maksim Sinyuk2, Praveena S Thiagarajan2, Awad M Jarrar2, Soumya M Turaga2, Caner Saygin2, Erin Mulkearns-Hubert2, Masahiro Hitomi2, Jeremy N Rich3,4,5, Stanton L Gerson4,5,6, Justin D Lathia2,4,5, Huiping Liu7,4,5,8,9.
Abstract
The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20-23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists. Cancer Res; 77(19); 5222-7. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28928129 PMCID： PMC5833988 DOI： 10.1158/0008-5472.CAN-17-0054
Source DB: PubMed Journal: Cancer Res ISSN： 0008-5472 Impact factor: 12.701